Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2024-03-11 00:00:00 ET · period of report 2023-03-10 · accession 0001214659-24-004302 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-11 | 2023-03-10 | AQST | Wargacki Stephen | SVP, Research, Development | F - Tax | $0.79 | -1,981 | 158.4K | -1% | -$1,565 |
| D | 2024-03-11 | 2024-03-07 | AQST | Wargacki Stephen | SVP, Research, Development | A - Grant | $0.00 | +112.5K | 270.9K | +71% | $0 |
| D | 2024-03-11 | 2024-03-07 | AQST | Wargacki Stephen | SVP, Research, Development | A - Grant | $0.00 | +56.2K | 56.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-10 | F | D | 1,981 | $0.79 | 158,419 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. (F2) The original Form 3, filed on 1/1/23, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the inclusion of shares vested that occurred on 3/10/22 as a total of 4,663 shares vested and owned when in fact 3,107 shares of the Issuer's common stock were owned, net of taxes withheld. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 1,556 shares reflecting share withheld for the payment of taxes. |
| 2 | Common | Common Stock | 2024-03-07 | A | A | 112,500 | $0.00 | 270,919 | D | — | — | (F3) The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-07 | A | A | 56,250 | $0.00 | 56,250 | D | $5.68 · — to 2034-03-07 | 56,250 Common Stock | (F4) The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |